These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
693 related articles for article (PubMed ID: 16903981)
41. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829 [TBL] [Abstract][Full Text] [Related]
42. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria. Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327 [TBL] [Abstract][Full Text] [Related]
43. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473 [TBL] [Abstract][Full Text] [Related]
44. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history]. Juzbasic S; Spina M; Vaccher E; Tirelli U Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662 [TBL] [Abstract][Full Text] [Related]
45. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients]. Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446 [TBL] [Abstract][Full Text] [Related]
46. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565 [TBL] [Abstract][Full Text] [Related]
47. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center. Sharma A; Bajpai J; Raina V; Mohanti BK Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788 [TBL] [Abstract][Full Text] [Related]
48. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States. Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786 [TBL] [Abstract][Full Text] [Related]
49. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Heard I; Potard V; Costagliola D Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379 [TBL] [Abstract][Full Text] [Related]
50. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era? Clayton A; Mughal T Hematol Oncol; 2004 Sep; 22(3):111-20. PubMed ID: 15991221 [TBL] [Abstract][Full Text] [Related]
51. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy. Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680 [TBL] [Abstract][Full Text] [Related]
55. AIDS-associated malignancies. Krown SE Cancer Chemother Biol Response Modif; 1996; 16():441-61. PubMed ID: 8639393 [TBL] [Abstract][Full Text] [Related]
56. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre. Kiely B; O'Flaherty J; Surah S; Kieran J; O'Donnell D; Bergin C; Mulcahy F Int J STD AIDS; 2010 May; 21(5):332-6. PubMed ID: 20498102 [TBL] [Abstract][Full Text] [Related]
57. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART. Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657 [TBL] [Abstract][Full Text] [Related]
58. Immune deficiency and risk for malignancy among persons with AIDS. Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705 [TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy. Aboulafia DM Cancer Pract; 1994; 2(4):297-306. PubMed ID: 7858657 [TBL] [Abstract][Full Text] [Related]
60. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F; Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]